Transcriptome analyses suggest minimal effects of Shank3 dosage on directional gene expression changes in the mouse striatum

Yeunkum Lee, Hyojin Kang, Chunmei Jin, Yinhua Zhang, Yoonhee Kim, Kihoon Han

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Both deletions and duplications of the SH3 and multiple ankyrin repeat domains 3 (SHANK3) gene, encoding excitatory postsynaptic scaffolds, are causally associated with various brain disorders, suggesting that proper Shank3 dosage is critical for normal brain development and function. In addition to its well-established synaptic functions, recent studies have suggested that Shank3 can also affect gene expression in the nucleus. However, it has not been investigated whether there are a group of genes whose directional expression is regulated in a Shank3 dosage-dependent manner (i.e. showing opposite changes in expression following Shank3 reduction and overexpression). This is an important issue to be examined for better understanding why neuronal development and function are sensitive to Shank3 dosage, and how much transcriptional changes contribute to neuronal phenotypes affected by Shank3 dosage. To examine this, we performed transcriptome analyses on the striatum of Shank3 heterozygous and knock-out mice, which identified three and 17 differentially expressed genes, respectively. We then compared the results to those of our previous striatal transcriptome analysis of Shank3 overexpressing mice and identified 31 candidate genes showing directional expression changes in a Shank3 dosage-dependent manner. However, overall, their Shank3 dosage-dependent fold changes were very subtle (average of absolute log2(fold change) was 0.139). Meanwhile, the gene set enrichment analyses of the striatal transcriptome suggested that Shank3 dosage may affect anchoring junction-related functions. Taken together, these results suggest that Shank3 dosage minimally affects directional gene expression changes in the mouse striatum.

Original languageEnglish
JournalAnimal Cells and Systems
DOIs
Publication statusPublished - 2019 Jan 1

Fingerprint

Gene Expression Profiling
Gene expression
transcriptome
dose response
Genes
Gene Expression
gene expression
mice
Corpus Striatum
dosage
Brain
Ankyrin Repeat
Gene encoding
Scaffolds (biology)
genes
Brain Diseases
Knockout Mice
ankyrins
brain
Phenotype

Keywords

  • Shank3 dosage
  • striatum
  • transcriptome

ASJC Scopus subject areas

  • Animal Science and Zoology
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Transcriptome analyses suggest minimal effects of Shank3 dosage on directional gene expression changes in the mouse striatum. / Lee, Yeunkum; Kang, Hyojin; Jin, Chunmei; Zhang, Yinhua; Kim, Yoonhee; Han, Kihoon.

In: Animal Cells and Systems, 01.01.2019.

Research output: Contribution to journalArticle

@article{cc008456d6744e28a694f731385b86a5,
title = "Transcriptome analyses suggest minimal effects of Shank3 dosage on directional gene expression changes in the mouse striatum",
abstract = "Both deletions and duplications of the SH3 and multiple ankyrin repeat domains 3 (SHANK3) gene, encoding excitatory postsynaptic scaffolds, are causally associated with various brain disorders, suggesting that proper Shank3 dosage is critical for normal brain development and function. In addition to its well-established synaptic functions, recent studies have suggested that Shank3 can also affect gene expression in the nucleus. However, it has not been investigated whether there are a group of genes whose directional expression is regulated in a Shank3 dosage-dependent manner (i.e. showing opposite changes in expression following Shank3 reduction and overexpression). This is an important issue to be examined for better understanding why neuronal development and function are sensitive to Shank3 dosage, and how much transcriptional changes contribute to neuronal phenotypes affected by Shank3 dosage. To examine this, we performed transcriptome analyses on the striatum of Shank3 heterozygous and knock-out mice, which identified three and 17 differentially expressed genes, respectively. We then compared the results to those of our previous striatal transcriptome analysis of Shank3 overexpressing mice and identified 31 candidate genes showing directional expression changes in a Shank3 dosage-dependent manner. However, overall, their Shank3 dosage-dependent fold changes were very subtle (average of absolute log2(fold change) was 0.139). Meanwhile, the gene set enrichment analyses of the striatal transcriptome suggested that Shank3 dosage may affect anchoring junction-related functions. Taken together, these results suggest that Shank3 dosage minimally affects directional gene expression changes in the mouse striatum.",
keywords = "Shank3 dosage, striatum, transcriptome",
author = "Yeunkum Lee and Hyojin Kang and Chunmei Jin and Yinhua Zhang and Yoonhee Kim and Kihoon Han",
year = "2019",
month = "1",
day = "1",
doi = "10.1080/19768354.2019.1595142",
language = "English",
journal = "Animal Cells and Systems",
issn = "1976-8354",
publisher = "Taylor and Francis Ltd.",

}

TY - JOUR

T1 - Transcriptome analyses suggest minimal effects of Shank3 dosage on directional gene expression changes in the mouse striatum

AU - Lee, Yeunkum

AU - Kang, Hyojin

AU - Jin, Chunmei

AU - Zhang, Yinhua

AU - Kim, Yoonhee

AU - Han, Kihoon

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Both deletions and duplications of the SH3 and multiple ankyrin repeat domains 3 (SHANK3) gene, encoding excitatory postsynaptic scaffolds, are causally associated with various brain disorders, suggesting that proper Shank3 dosage is critical for normal brain development and function. In addition to its well-established synaptic functions, recent studies have suggested that Shank3 can also affect gene expression in the nucleus. However, it has not been investigated whether there are a group of genes whose directional expression is regulated in a Shank3 dosage-dependent manner (i.e. showing opposite changes in expression following Shank3 reduction and overexpression). This is an important issue to be examined for better understanding why neuronal development and function are sensitive to Shank3 dosage, and how much transcriptional changes contribute to neuronal phenotypes affected by Shank3 dosage. To examine this, we performed transcriptome analyses on the striatum of Shank3 heterozygous and knock-out mice, which identified three and 17 differentially expressed genes, respectively. We then compared the results to those of our previous striatal transcriptome analysis of Shank3 overexpressing mice and identified 31 candidate genes showing directional expression changes in a Shank3 dosage-dependent manner. However, overall, their Shank3 dosage-dependent fold changes were very subtle (average of absolute log2(fold change) was 0.139). Meanwhile, the gene set enrichment analyses of the striatal transcriptome suggested that Shank3 dosage may affect anchoring junction-related functions. Taken together, these results suggest that Shank3 dosage minimally affects directional gene expression changes in the mouse striatum.

AB - Both deletions and duplications of the SH3 and multiple ankyrin repeat domains 3 (SHANK3) gene, encoding excitatory postsynaptic scaffolds, are causally associated with various brain disorders, suggesting that proper Shank3 dosage is critical for normal brain development and function. In addition to its well-established synaptic functions, recent studies have suggested that Shank3 can also affect gene expression in the nucleus. However, it has not been investigated whether there are a group of genes whose directional expression is regulated in a Shank3 dosage-dependent manner (i.e. showing opposite changes in expression following Shank3 reduction and overexpression). This is an important issue to be examined for better understanding why neuronal development and function are sensitive to Shank3 dosage, and how much transcriptional changes contribute to neuronal phenotypes affected by Shank3 dosage. To examine this, we performed transcriptome analyses on the striatum of Shank3 heterozygous and knock-out mice, which identified three and 17 differentially expressed genes, respectively. We then compared the results to those of our previous striatal transcriptome analysis of Shank3 overexpressing mice and identified 31 candidate genes showing directional expression changes in a Shank3 dosage-dependent manner. However, overall, their Shank3 dosage-dependent fold changes were very subtle (average of absolute log2(fold change) was 0.139). Meanwhile, the gene set enrichment analyses of the striatal transcriptome suggested that Shank3 dosage may affect anchoring junction-related functions. Taken together, these results suggest that Shank3 dosage minimally affects directional gene expression changes in the mouse striatum.

KW - Shank3 dosage

KW - striatum

KW - transcriptome

UR - http://www.scopus.com/inward/record.url?scp=85064496097&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064496097&partnerID=8YFLogxK

U2 - 10.1080/19768354.2019.1595142

DO - 10.1080/19768354.2019.1595142

M3 - Article

AN - SCOPUS:85064496097

JO - Animal Cells and Systems

JF - Animal Cells and Systems

SN - 1976-8354

ER -